April 26, 2019
Rose
There's been more and more scrutiny over how pharma companies use patents to find loopholes in anti-competition laws. Now Sen. John Cornyn (R-Texas) is going after a practice where companies make minor formula adjustments to prevent generic substitutions. In other pharmaceutical news: more kickback settlements, pharma-funded charities, first-quarter profits, copays and more.
from Kaiser Health News http://bit.ly/2vmYTR1
April 26, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
From The State Capitols: Youth Tackle Football Ban; Surprise Medical Bill Solution; Medicaid Co-Pays; ‘Shared Savings’ Plans; And More- Longer Looks: The Minimum Wage And Public Health; The Jail-Health Care Crisis; And Bringing Down Drug Prices
- Perspectives: Administration’s New Rule Is No Way To Reduce Number Of Abortions; Americans Of Faith Need To Speak Out Against Setting Obstacles In Path To Abortion
- Viewpoints: Why Are The Heroes Of 9/11 Having To Beg Congress For Help?; The Pharma Industry Has Gotten Away With Forgetting The Needs Of The Uninsured
- State Highlights: New York Seeks Information From Facebook, App Makers About Sharing Of Personal Data; Cleveland Clinic Aims To Double Number Of Patients It Treats
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment